‘Fantastic’ bonds kick Roche loan into touch
Roche’s plans for a jumbo loan have been thrown into doubt after the Swiss drugs group issued more than $14bn of bonds in Europe this week, adding to the $16bn trade it made last week in the US. The bonds mean Roche has little need to tap the bank market to fund its $42bn hostile bid for Genentech.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
